| Pharmaceutical active ingredients: |
| Lovastatin |
| Available forms, composition and doses of Hipolip: |
| N / A |
| Hipolip medical category: |
| Human:Dyslipidaemic agentsHMG-COA reductase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C10AA02 - Lovastatin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Hi-O-Dide | Ethylenediamine Dihydroiodide | Unidentified Pharmaceutical Company |
| Hipercilina | Penicillin | Unidentified Pharmaceutical Company |
| Hiphyllin | Dyphylline | Unidentified Pharmaceutical Company |
| Hipnax | Nitrazepam | Unidentified Pharmaceutical Company |
| Hipoftalin | Hydralazine | Unidentified Pharmaceutical Company |
| Hiposerpil | Reserpine | Unidentified Pharmaceutical Company |
| Hipox | Hydrogen Peroxide | Unidentified Pharmaceutical Company |
| Hippodin | Iodohippurate Sodium | Unidentified Pharmaceutical Company |
| Hippuzon | Thalidomide | Unidentified Pharmaceutical Company |
| Hipsal | Nitrazepam | Unidentified Pharmaceutical Company |